Articles tagged with "plaque psoriasis"

FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review

December 3, 2018 • By Michele B. Kaufman, PharmD, BCGP

Plaque Psoriasis Treatments: BMS-986165 Promising & Adalimumab Biosimilar Demonstrates Equivalence

October 22, 2018 • By Michele B. Kaufman, PharmD, BCGP

Revised Application Expected for IV Meloxicam; Plus EU Approves Tildrakizumab

October 9, 2018 • By Michele B. Kaufman, PharmD, BCGP

Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis

June 18, 2018 • By Michele B. Kaufman, PharmD, BCGP

FDA to Review Abuse-Deterrent Oxycodone Capsule

May 18, 2018 • By Michele B. Kaufman, PharmD, BCGP

International Approvals for Guselkumab & Anakinra; Plus Adalimumab Biosimilar in Europe

April 30, 2018 • By Michele B. Kaufman, PharmD, BCGP

Risankizumab Promising for Psoriasis; Plus Canada Approves Brodalumab

March 21, 2018 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Hip Fracture Rates After Bisphosphonate Drug Holidays, Plus More on Golimumab, Ustekinumab

December 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

Ustekinumab Approved for Use in Adolescents with Plaque Psoriasis

November 3, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab

October 17, 2017 • By Mary Beth Nierengarten